Ducommun Sets Financial Targets; Sales To Reach ~$950M+ By 2027; Adjusted EBITDA Margins To ~18%; Raises Its Acquisition Range By Up To 3–5x, Pursuing Targets In The $300M-$500M Range While Continuing To Pursue Bolt-Ons